BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15285304)

  • 1. Reporting of "LSIL with ASC-H" on cervicovaginal smears: is it a valid category to predict cases with HSIL follow-up?
    Kir G; Cetiner H; Gurbuz A; Karateke A
    Eur J Gynaecol Oncol; 2004; 25(4):462-4. PubMed ID: 15285304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the low-grade squamous intraepithelial lesion/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion category associated with cervical intraepithelial neoplasia 2?
    Cetiner H; Kır G; Kaygusuz E; Sağlıcan Y; Kabaca C
    Acta Cytol; 2013; 57(6):581-4. PubMed ID: 24107612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
    Nasser SM; Cibas ES; Crum CP; Faquin WC
    Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
    Ince U; Aydin O; Peker O
    Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion.
    Alsharif M; Kjeldahl K; Curran C; Miller S; Gulbahce HE; Pambuccian SE
    Cancer; 2009 Apr; 117(2):92-100. PubMed ID: 19365830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
    Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
    Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of "squamous intraepithelial lesion of indeterminate grade" as a distinct cytologic category.
    Wong D; Teschendorf C; Lin GY; Hasteh F
    Am J Clin Pathol; 2012 May; 137(5):753-60. PubMed ID: 22523214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
    Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preceding cervical cytology in women with high-grade squamous intraepithelial lesion.
    Songveeratham S; Kietpeerakool C; Khunamornpong S; Sribanditmongkol N; Srisomboon J
    Arch Gynecol Obstet; 2011 Jun; 283(6):1381-4. PubMed ID: 20607262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
    Elsheikh TM; Kirkpatrick JL; Wu HH
    Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the diagnosis "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" in pregnant women.
    Onuma K; Saad RS; Kanbour-Shakir A; Kanbour AI; Dabbs DJ
    Cancer; 2006 Oct; 108(5):282-7. PubMed ID: 16991139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical dysplasia in adolescents.
    Wright JD; Davila RM; Pinto KR; Merritt DF; Gibb RK; Rader JS; Mutch DG; Gao F; Powell MA
    Obstet Gynecol; 2005 Jul; 106(1):115-20. PubMed ID: 15994625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
    Zhou H; Schwartz MR; Coffey D; Smith D; Mody DR; Ge Y
    Cancer Cytopathol; 2012 Dec; 120(6):373-9. PubMed ID: 22648956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for increasing usage of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) Pap test interpretations.
    Walavalkar V; Tommet D; Fischer AH; Liu Y; Papa DM; Owens CL
    Cancer Cytopathol; 2014 Feb; 122(2):123-7. PubMed ID: 23983192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence.
    Owens CL; Moats DR; Burroughs FH; Gustafson KS
    Am J Clin Pathol; 2007 Sep; 128(3):398-403. PubMed ID: 17709313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.